Apparent treatment-resistant hypertension among individuals with history of stroke or transient ischemic attack

American Journal of Medicine

Volumn 128, Issue 7, 2015, Pages 707-714.e2

  Howard, Virginia J ^a   Tanner, Rikki M ^a   Anderson, Aaron ^b   Irvin, Marguerite R ^a   Calhoun, David A ^c   Lackland, Daniel T ^d   Oparil, Suzanne ^c   Muntner, Paul ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Predictors; Prevalence; Resistant hypertension; Secondary prevention; Stroke; Transient ischemic attack

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; BLACK PERSON; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RESISTANT HYPERTENSION; REVIEW; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; WAIST CIRCUMFERENCE; AGE DISTRIBUTION; AGED; BLOOD PRESSURE MEASUREMENT; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRUG RESISTANCE; FACTUAL DATABASE; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; STROKE; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; COMORBIDITY; CONFIDENCE INTERVALS; DATABASES, FACTUAL; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STROKE; SURVIVAL RATE;

EID: 84931568758     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.02.008     Document Type: Article

References (40)

1. J.F. Meschia, C. Bushnell, and B. Boden-Albala Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 45 12 2014 3754 3832
2. W.N. Kernan, B. Ovbiagele, and H.R. Black Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 45 7 2014 2160 2236
3. J.F. Toole, M.R. Malinow, and L.E. Chambless Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 291 5 2004 565 575
4. S.L. Paul, and A.G. Thrift Control of hypertension 5 years after stroke in the North East Melbourne Stroke Incidence Study Hypertension 48 2 2006 260 265
5. M. Kesarwani, A. Perez, V.A. Lopez, N.D. Wong, and S.S. Franklin Cardiovascular comorbidities and blood pressure control in stroke survivors J Hypertens 27 5 2009 1056 1063
6. N.D. Wong, V.A. Lopez, G. L'Italien, R. Chen, S.E. Kline, and S.S. Franklin Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004 Arch Intern Med 167 22 2007 2431 2436
7. C.L. White, P.E. Pergola, and J.M. Szychowski Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial Am J Hypertens 26 9 2013 1114 1122
8. P. Rashid, J. Leonardi-Bee, and P. Bath Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review Stroke 34 11 2003 2741 2748
9. M.R. Law, J.K. Morris, and N.J. Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665
10. S.E. Lakhan, and M.T. Sapko Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis Int Arch Med 2 1 2009 30
11. M.S. Mouradian, S.R. Majumdar, A. Senthilselvan, K. Khan, and A. Shuaib How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke 33 6 2002 1656 1659
12. D.A. Brenner, R.M. Zweifler, and C.R. Gomez Awareness, treatment, and control of vascular risk factors among stroke survivors J Stroke Cerebrovasc Dis 19 4 2010 311 320
13. C.L. Roumie, S. Ofner, and J.S. Ross Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort Circ Cardiovasc Qual Outcomes 4 4 2011 399 407
14. K.L. Olson, L.J. Lash, and T. Delate Ambulatory treatment gaps in patients with ischemic stroke or transient ischemic attack Permanente J 17 3 2013 28 34
15. S. Ruland, R. Raman, S. Chaturvedi, S. Leurgans, P.B. Gorelick Study AIAAASP Awareness, treatment, and control of vascular risk factors in African Americans with stroke Neurology 60 1 2003 64 68
16. N.S. Shah, M.D. Huffman, H. Ning, and D.M. Lloyd-Jones Trends in vascular risk factor treatment and control in US stroke survivors: the National Health and Nutrition Examination Surveys (1999-2010) Circ Cardiovasc Qual Outcomes 6 3 2013 270 277
17. D.A. Levine, C.I. Kiefe, G. Howard, V.J. Howard, O.D. Williams, and J.J. Allison Reduced medication access: a marker for vulnerability in US stroke survivors Stroke 38 2007 1557 1564
18. C.D. Bushnell, D.M. Olson, and X. Zhao Secondary preventive medication persistence and adherence 1 year after stroke Neurology 77 12 2011 1182 1190
19. D.A. Calhoun, D. Jones, and S. Textor Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation 117 25 2008 e510 e526
20. D.T. Lackland, M.S. Elkind, and R. D'Agostino Sr Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 43 7 2012 1998 2027
21. P.A. James, S. Oparil, and B.L. Carter 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 5 2014 507 520
22. V.J. Howard, M. Cushman, and L. Pulley The reasons for geographic and racial differences in stroke study: objectives and design Neuroepidemiology 25 3 2005 135 143
23. S.R. Gillett, R.H. Boyle, N.A. Zakai, L.A. McClure, N.S. Jenny, and M. Cushman Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort Clin Biochem 47 16-17 2014 243 246
24. G. Howard, R. Anderson, N.J. Johnson, P. Sorlie, G. Russell, and V.J. Howard Evaluation of social status as a contributing factor to the stroke belt region of the United States Stroke 28 1997 936 940
25. D.J. Lanska, and L.H. Kuller The geography of stroke mortality in the United States and the concept of a stroke belt Stroke 26 1995 1145 1149
26. V.J. Howard, R.F. Woolson, and B.M. Egan Prevalence of hypertension by duration and age at exposure to the stroke belt J Am Soc Hypertens 4 1 2010 32 41
27. R.M. Tanner, D.A. Calhoun, and E.K. Bell Prevalence of apparent treatment-resistant hypertension among individuals with CKD Clin J Am Soc Nephrol 8 9 2013 1583 1590
28. M.R. Irvin, D. Shimbo, and D.M. Mann Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension J Clin Hypertens 14 10 2012 694 700
29. A.V. Chobanian, G.L. Bakris, and H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 19 2003 2560 2572
30. D.E. Morisky, L.W. Green, and D.M. Levine Concurrent and predictive validity of a self-reported measure of medication adherence Med Care 24 1 1986 67 74
31. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
32. R.L. Sacco, R. Adams, and G. Albers Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline Stroke 37 2 2006 577 617
33. Group PC Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack Lancet 358 9287 2001 1033 1041
34. S. Bangalore, L. Schwamm, and E.E. Smith Secondary prevention after ischemic stroke or transient ischemic attack Am J Med 127 8 2014 728 738
35. A. Towfighi, D. Markovic, and B. Ovbiagele Consistency of blood pressure control after ischemic stroke: prevalence and prognosis Stroke 45 5 2014 1313 1317
36. J.J. Sim, S.K. Bhandari, and J. Shi Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system Mayo Clin Proc 88 10 2013 1099 1107
37. J.D. Spence, and R.H. Llinas Albuminuria and risk of stroke in African Americans: a marker of uncontrolled hypertension? Neurology 79 16 2012 1634 1635
38. J.D. Spence Lessons from Africa: the importance of measuring plasma renin and aldosterone in resistant hypertension Can J Cardiol 28 3 2012 254 257
39. S.E. Judd, D.O. Kleindorfer, and L.A. McClure Self-report of stroke, transient ischemic attack, or stroke symptoms and risk of future stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study Stroke 44 1 2013 55 60
40. T. Engstad, K.H. Bonaa, and M. Viitanen Validity of self-reported stroke: The Tromso Study Stroke 31 7 2000 1602 1607